Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 22, 2026 08:30 ET | Source: BioMedWire

Next-Generation DNA Repair Therapies Open New Frontiers in Oncology

AUSTIN, Texas, June 22, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Cancer research is entering one of its most dynamic periods in decades. The class of drugs known as DNA Damage...
June 22, 2026 08:30 ET | Source: FibroBiologics, Inc.

FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing

HOUSTON, June 22, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the...
June 22, 2026 08:30 ET | Source: BioMedWire

Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis

AUSTIN, Texas, June 22, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) robs people of control over their own bodies — slowly, relentlessly and without a cure. More...
June 22, 2026 08:30 ET | Source: NetworkNewsWire

NetworkNews Audio Announces Audio Press Release (APR) Discussing AI Infrastructure Demand Creating Urgent Need for Scalable, Intelligent Automation

AUSTIN, Texas, June 22, 2026 (GLOBE NEWSWIRE) -- via IBN -- NetworkNewsAudio announces the Audio Press Release (APR) titled “AI Infrastructure Boom Drives Demand for Semiconductor, Pharmaceutical...
June 22, 2026 08:05 ET | Source: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (COVE-3) of its Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts

– Development Partner Torii Pharmaceutical also recently announced dosing of the first Japanese patient in this trial evaluating YCANTH (TO-208) in Japan – – Verrica maintains ownership of global...
June 22, 2026 08:00 ET | Source: AgEagle Aerial Systems, Inc.

EagleNXT Secures Order of eBee VISION ISR and eBee TAC Systems from Asia Pacific Customer

Two eBee VISION and three eBee TAC drones to support advanced ISR, tactical mapping, and operational readiness in the region ALLEN, Texas, June 22, 2026 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems...
June 22, 2026 08:00 ET | Source: Viking Acquisition Corp. I

NorthStar Secures Over CAD$40M with 3 Canadian Space Division to Advance Sovereign Space Domain Awareness

Viking Acquisition Corp. I (NYSE: VACI), a Cayman Islands exempted company, announced that its proposed business combination partner, NorthStar Earth & Spa
June 22, 2026 08:00 ET | Source: Aptorum Group Ltd

Aptorum Group Announces Collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer’s Disease Biomarkers

NEW YORK, NY; NEW HAVEN, CT; and PRINCETON, NJ, June 22, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company...
June 22, 2026 08:00 ET | Source: GuideAI Health Corp.

GuideAI Health Receives FDA 510(k) Clearance for VascularAssist Occlusion Triage

BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. ("GuideAI" or the "Company") is pleased to announce that it has received 510(k) clearance from the U.S. Food and Drug Administration...
June 22, 2026 08:00 ET | Source: Autonomix Medical, Inc.

Autonomix Medical Announces Standalone Neural Sensing Program with Evidence of Real-Time Renal Nerve Activity Change

Platform Expected to Target Expansion into Multi-Billion-Dollar Cardiovascular Market with Potential Class II Diagnostic Regulatory Path Architecture Supports Future Expansion into Denervation,...